The dual inhibition of G9a and DNA methyltransferase (DNMT) leads to increased tumor infiltrations of NK and CD8+ T cells, enhanced responses to PD-L1 blockade, and facilitated tumor regression in a mouse model of bladder cancer. This evidence concerns the gene DNMT1 and urinary bladder cancer.